Viewing Study NCT04815356


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-04-11 @ 12:11 PM
Study NCT ID: NCT04815356
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2021-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module